BioXcel Therapeutics, Inc. - Common Stock (NQ:BTAI)

ROSEN, A TRUSTED AND LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – BTAI

August 16, 2023

From The Rosen Law Firm PA

Major changes are afoot with the company, and few are happy about them.

Why BioXcel Therapeutics Stock Flopped Again Today ↗

August 15, 2023

Via The Motley Fool

Challenging Horizon For BioXcel: Analysts Dive Into Igalmi's Potential And Reshaped Commercialization Strategy ↗

August 15, 2023

Mizuho analyst Graig Suvannavejh downgraded BioXcel Therapeutics, Inc. (NASDAQ: BTAI) to Neutral from Buy,

Via Benzinga

Analyst Expectations for BioXcel Therapeutics's Future ↗

August 15, 2023

Via Benzinga

A Preview Of BioXcel Therapeutics's Earnings ↗

August 11, 2023

Via Benzinga

Benzinga's Top Ratings Upgrades, Downgrades For August 15, 2023 ↗

August 15, 2023

Via Benzinga

NVIDIA To Rally More Than 23%? Here Are 10 Other Analyst Forecasts For Tuesday ↗

August 15, 2023

B of A Securities lowered the price target for Valero Energy Corporation (NYSE: BMBL) from $160 to $152. B of A Securities analyst Doug Leggate downgraded the stock from Buy to Neutral. Valero Energy...

Via Benzinga

ROSEN, A LEADING LAW FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

August 14, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Lost Money in BioXcel Therapeutics, Inc? Gibbs Law Group Investigates Potential Securities Law Violations

Topics Lawsuit

August 14, 2023

From Gibbs Law Group

Via Business Wire

Crude Oil Down 1%; Zynerba Pharmaceuticals Shares Spike Higher ↗

August 14, 2023

U.S. stocks traded mixed toward the end of trading, with the Nasdaq Composite gaining around 90 points on Monday. The Dow traded down 0.14% to 35,232.62 while the NASDAQ rose 0.66% to 13,735.42. The...

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Intraday Session ↗

August 14, 2023

Via Benzinga

3 Biotech Stocks to Sell in August Before They Crash and Burn ↗

August 14, 2023

These biotech stocks are set to crash and burn, so it's probably a good idea for investors to sell in August, before it's too late.

Why 22nd Century Group Are Trading Lower By Around 20%? Here Are Other Stocks Moving In Monday's Mid-Day Session ↗

August 14, 2023

Gainers Zynerba Pharmaceuticals, Inc. (NASDAQ: ZYNE) shares jumped 283.7% to $1.3007 after Harmony Biosciences entered into definitive agreement to acquire the company for total potential consideration...

Via Benzinga

US Stocks Turn Higher; BioXcel Therapeutics Shares Plummet ↗

August 14, 2023

U.S. stocks traded mostly higher midway through trading, with the Nasdaq Composite gaining more than 80 points on Monday. The Dow traded up 0.01% to 35,284.34 while the NASDAQ rose 0.64% to 13,732.05....

Via Benzinga

Topics Stocks

Why BioXcel Therapeutics Stock Is Getting Crushed Today ↗

August 14, 2023

BioXcel just announced a big change.

Via The Motley Fool

CLF Stock Alert: U.S. Steel Rejects Cleveland-Cliffs Bid ↗

August 14, 2023

Cleveland-Cliffs (CLF) stock is worth checking on today after the company's takeover bill for United States Steel (X) was rejected.

Faraday Future (FFIE) stock is a hot topic on Monday after the EV company delivered its first FF 91 2.0 Futurist Alliance.

FFIE Stock Alert: Faraday Future Delivers Its First FF 91 ↗

August 14, 2023

PayPal (PYPL) stock is in the news Monday as investors react to the finance transfer company naming Alex Chriss as its next CEO.

PYPL Stock Alert: What to Know as PayPal Names New CEO ↗

August 14, 2023

BioXcel Therapeutics (BTAI) stock is taking a beating on Monday after the biopharmaceutical company announced major layoffs.

Why Is BioXcel Therapeutics (BTAI) Stock Down 46% Today? ↗

August 14, 2023

U.S. stocks traded mostly lower this morning, with the Dow Jones falling around 50 points on Monday. Following the market opening Monday, The Dow traded down 0.14% to 35,230.38 while the NASDAQ fell...

Dow Falls 50 Points; Monday.com Posts Upbeat Results ↗

August 14, 2023

Via Benzinga

Topics Stocks

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

August 14, 2023

Via Benzinga

BTAI DEADLINE ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against BioXcel Therapeutics, Inc.

August 14, 2023

From Bernstein Liebhard LLP

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

August 13, 2023

WHY: New York, NY - (NewMediaWire) - August 13, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...

Via TheNewswire.com

Topics Lawsuit

ROSEN, NATIONAL INVESTOR COUNSEL, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

August 13, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

ROSEN, A RESPECTED AND LEADING FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

Topics Lawsuit

August 12, 2023

WHY: New York, NY - (NewMediaWire) - August 12, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...

Via TheNewswire.com

Topics Lawsuit

ROSEN, A RESPECTED AND LEADING FIRM, Encourages BioXcel Therapeutics, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

August 12, 2023

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against GDS, Arrow, ImmunityBio, and BioXcel and Encourages Investors to Contact the Firm

Topics Lawsuit

August 11, 2023

From Bragar Eagel & Squire

NASDAQ: BTAI Investor Notice Lawsuit Alleges Securities Laws Violations by BioXcel Therapeutics, Inc. ↗

August 11, 2023

San Diego, CA -- (SBWIRE) -- 08/11/2023 -- An investor, who purchased shares of BioXcel Therapeutics, Inc. (NASDAQ: BTAI), filed a lawsuit over alleged violations of Federal Securities Laws by BioXcel...

Via SBWire

Topics Lawsuit

ROSEN, A LEADING NATIONAL FIRM, Encourages BioXcel Therapeutics, Inc. Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action - BTAI

August 08, 2023

WHY: New York, NY - (NewMediaWire) - August 08, 2023 - Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of BioXcel Therapeutics, Inc. (NASDAQ: BTAI) between December...